- Home
- SLGL vs MAXN Comparison
SLGL vs MAXN Comparison
Compare SLGL & MAXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLGL
- MAXN
- Stock Information
- Founded
- SLGL 1997
- MAXN 2019
- Country
- SLGL Israel
- MAXN Singapore
- Employees
- SLGL N/A
- MAXN N/A
- Industry
- SLGL Biotechnology: Pharmaceutical Preparations
- MAXN Semiconductors
- Sector
- SLGL Health Care
- MAXN Technology
- Exchange
- SLGL Nasdaq
- MAXN Nasdaq
- Market Cap
- SLGL 69.1M
- MAXN 56.0M
- IPO Year
- SLGL 2018
- MAXN N/A
- Fundamental
- Price
- SLGL $23.98
- MAXN $4.05
- Analyst Decision
- SLGL
- MAXN Sell
- Analyst Count
- SLGL 0
- MAXN 1
- Target Price
- SLGL N/A
- MAXN $4.00
- AVG Volume (30 Days)
- SLGL 33.1K
- MAXN 123.0K
- Earning Date
- SLGL 11-14-2025
- MAXN 08-14-2025
- Dividend Yield
- SLGL N/A
- MAXN N/A
- EPS Growth
- SLGL N/A
- MAXN N/A
- EPS
- SLGL N/A
- MAXN N/A
- Revenue
- SLGL $23,931,000.00
- MAXN $176,414,000.00
- Revenue This Year
- SLGL N/A
- MAXN $100.37
- Revenue Next Year
- SLGL $31.17
- MAXN $24.61
- P/E Ratio
- SLGL N/A
- MAXN N/A
- Revenue Growth
- SLGL 264.86
- MAXN N/A
- 52 Week Low
- SLGL $4.01
- MAXN $2.49
- 52 Week High
- SLGL $30.00
- MAXN $14.49
- Technical
- Relative Strength Index (RSI)
- SLGL 58.56
- MAXN 53.94
- Support Level
- SLGL $23.13
- MAXN $3.76
- Resistance Level
- SLGL $24.85
- MAXN $4.06
- Average True Range (ATR)
- SLGL 2.36
- MAXN 0.28
- MACD
- SLGL -0.43
- MAXN 0.02
- Stochastic Oscillator
- SLGL 39.19
- MAXN 58.06
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
About MAXN Maxeon Solar Technologies Ltd.
Maxeon Solar Technologies Ltd is engaged in the manufacturing and marketing of premium solar technology. It owns and operates solar cell and panel manufacturing facilities located in Malaysia, Mexico, and the Philippines. The company's primary products are the Maxeon line of interdigitated back contact (IBC) solar cells and panels, and the Performance line (formerly, P-Series) of shingled solar cells and panels. the Maxeon line of solar panels are the highest-efficiency solar panels on the market with an aesthetically pleasing design, and the Performance line of solar panels offers a high-value and cost-effective solution. It is targeted at residential and small-scale commercial customers across the globe. The company derives its revenue from the United States, France, Italy, and others.